Brendon Stiles, MD, is Professor and Chief, Thoracic Surgery and Surgical Oncology, Department of Cardiothoracic & Vascular Surgery at Montefiore Einstein, and the Associate Director for Surgical Services in the Montefiore Einstein Cancer Center. Dr. Stiles’ clinical focus is on the treatment of lung and esophageal cancer and unusual thoracic cancers including metastatic tumors and those invading the heart. He also has a clinical interest in treating benign chest and upper gastrointestinal diseases. Taking a patient-first philosophy, Dr. Stiles provides world-class personalized care, using minimally invasive, organ-sparing techniques and targeting surgical therapy to the specific needs of the patient and his or her individual tumor.“The recruitment of Dr. Stiles elevates the treatment of lung cancer to a historic level,” said Robert E. Michler, MD, Surgeon-in-Chief and Chairman and Professor, Department of Surgery and Department of Cardiothoracic & Vascular Surgery at Montefiore-Einstein. “Every thoracic surgical therapy available anywhere in the world will now be offered by Dr. Stiles at Montefiore-Einstein.”After earning his Bachelor of Arts in 1994 at the University of Virginia, Dr. Stiles continued at UVA, earning his Doctor of Medicine in 1999.  He conducted his training in general surgery at the University of Virginia Health System. From 2001 to 2003, Dr. Stiles served as a surgical research fellow at Memorial Sloan-Kettering Cancer Center before returning to the University of Virginia Health System to complete his surgical residency. Dr. Stiles completed a cardiothoracic surgery residency at NewYork-Presbyterian Hospital-Weill Cornell and Memorial Sloan-Kettering Cancer Center in 2008. Dr. Stiles joined the faculty at NewYork-Presbyterian Hospital-Weill Cornell before being recruited by Dr. Michler to Montefiore-Einstein in 2021. Dr. Stiles is rated as an Elite provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, Lymphadenectomy, and Thymectomy.

Balazs Halmos, MD received his medical degree summa cum laude from Semmelweis University in Budapest, Hungary. He completed an internal medicine residency program at St. Dr. Halmos is rated as an Elite provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Elite provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Nasopharyngeal Carcinoma, and Prostatectomy.

Marjorie Zauderer is an Oncologist in Valhalla, New York. Dr. Zauderer is rated as an Elite provider by MediFind in the treatment of Lung Cancer. Her top areas of expertise are Mesothelioma, Lung Cancer, Metastatic Pleural Tumor, Lung Adenocarcinoma, and Orchiectomy.

Raja Flores is a Thoracic Surgeon in New York, New York. Dr. Flores is rated as an Elite provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Mesothelioma, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Thymectomy.

Kenneth Rosenzweig is a Radiation Oncologist in Astoria, New York. Dr. Rosenzweig is rated as an Elite provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Mesothelioma, Lung Cancer, Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC).

Jeffrey Port is a Thoracic Surgeon and a General Surgeon in Flushing, New York. Dr. Port is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Nodules, Thymectomy, and Lymphadenectomy.

Catherine Shu is an Oncologist in New York, New York. Dr. Shu has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Lung Cancer. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Salpingo-Oophorectomy.

Juan Wisnivesky is a Pulmonary Medicine provider in New York, New York. Dr. Wisnivesky is rated as an Elite provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Asthma, Non-Small Cell Lung Cancer (NSCLC), Nephrectomy, and Endoscopy.

Andrea Wolf is a Thoracic Surgeon in New York, New York. Dr. Wolf is rated as an Elite provider by MediFind in the treatment of Lung Cancer. Her top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreaticoduodenectomy, and Endoscopy.

Giuseppe Giaccone is a Hematologist Oncology specialist and an Oncologist in Flushing, New York. Dr. Giaccone is rated as an Elite provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Thymic Epithelial Tumor, Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy.

Dr. Dan Costin is Director of the White Plains Hospital Center for Cancer Care. He has been practicing medical oncology and hematology in Westchester since 1993. He received his B.S. in biochemistry at the University of California in Los Angeles and his medical degree at the University of California in San Francisco. He completed his internal medicine residency at Beth Israel Hospital in Boston in 1990, his fellowship in medical oncology at the National Cancer Institute in Bethesda in 1991, and his fellowship in hematology at New York University in 1993. He has been an attending physician at White Plains Hospital since 1993 and served as section chief of the department of Hematology-Oncology from 1999 to 2007. Dr. Costin is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Paget Disease of the Breast, Osteosarcoma, Chondrosarcoma, and Angiosarcoma.

Dr. Mittelman earned his medical degree from his medical degree from Mt. Sinai School of Medicine. He completed his internship at Elmhurst Hospital Center, Queens, and his internal medicine residency at State University of NY Health Science Center, Brooklyn. He completed a fellowship in oncology at Memorial Sloan Kettering Cancer Center in July 1983. Dr. Mittelman is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Colorectal Cancer.

Dr. Todd Weiser is the Chief of the Cardiothoracic Department at White Plains Hospital. A native New Yorker, Dr. Weiser joined the Division of Thoracic Surgery at White Plains Hospital Center in 2011 as Director of Thoracic Surgery, bringing state-of-the-art Thoracic surgery to the people of Westchester County and creating a destination service for the highest quality thoracic care. Dr. Weiser's main clinical interest is the surgical treatment of diseases and conditions of the chest and chest wall, specializing in surgical management of the trachea (airway) and minimally invasive treatment of lung cancer. Dr. Weiser is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Lung Nodules, Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Advanced Bronchoscopy.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Anal Cancer, Laryngeal Cancer, Throat Cancer, and Cervical Cancer.

Haiying Cheng is an Oncologist in Bronx, New York. Dr. Cheng is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Dr. Kalnicki focuses on researching and implementing new technologies in the radiation treatment of cancer, with the aim of enhancing the dose to the tumor target while preserving normal tissues from radiation injury, potentially increasing tumor control and improving quality of life. He pioneered the use of intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), target motion management with 4-D radiation planning, stereotactic body radiation therapy (SBRT) and functional tumor imaging with PET-CT (positron emission tomography – CAT scan) fusion techniques. His research has implications for radiation treatment planning and techniques used for most clinical situations in radiation oncology, including brain, head and neck, thoracic, upper abdominal and pelvic malignancies. Dr. Kalnicki is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Anal Cancer, Cervical Cancer, and Prostatectomy.

Roy Oommen is a Thoracic Surgeon and a General Surgeon in Eastchester, New York. Dr. Oommen is rated as an Advanced provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Gastrostomy.

Anthony Provenzano is a Hematologist Oncology specialist and an Oncologist in Eastchester, New York. Dr. Provenzano is rated as an Advanced provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Paget Disease of the Breast, Breast Cancer, and Non-Small Cell Lung Cancer (NSCLC).

Stephanie Smith-Marrone is an Oncologist in Bronxville, New York. Dr. Smith-Marrone is rated as an Advanced provider by MediFind in the treatment of Lung Cancer. Her top areas of expertise are Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.